Navigation Links
Mettler-Toledo International Inc. Announces Webcast of Presentation at Baird Industrial Conference
Date:11/3/2009

COLUMBUS, Ohio, Nov. 3 /PRNewswire-FirstCall/ -- Mettler-Toledo International Inc. (NYSE: MTD) today announced the webcast of its presentation at the Baird Industrial Conference in Chicago on Tuesday, November 10, 2009, at 8:20 a.m. Central Time (9:20 a.m. Eastern Time). To hear a live webcast of the presentation, visit the investor relations page on the Company's Web site at www.mt.com/investors. A replay of the webcast will be available for seven days.

METTLER TOLEDO is a leading global supplier of precision instruments and services. The Company is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The Company also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world's largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about METTLER TOLEDO can be found on the World Wide Web at "www.mt.com."

SOURCE Mettler-Toledo International Inc.


'/>"/>
SOURCE Mettler-Toledo International Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine technology :

1. Mettler-Toledo International Inc. Reports Third Quarter 2009 Results
2. PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
3. OC-Based Charity Teams with International Relief Organization in Holiday Fundraising Drive
4. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
5. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
6. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
7. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
8. Yongye International Announces Completion of Restructuring
9. Medizone International Announces Third Round of AsepticSure
10. With Flu Season Underway, International SOS to Host H1N1 Update Webinar
11. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., Mass., Nov. 25 Hologic...a leading developer, manufacturer and supplier of ...urgical products dedicated to serving the healthca...the Radiological Society of North America (RSNA) a...December 3, 2009 to highlight our new SecurView(&#...
(Date:11/25/2009)...DELPHIA, Nov. 25 ERT (Na... McKelvey, the Company,s President and CEO, and Ke...t and CFO, are scheduled to present at the 21st An...PM EST on December 1, 2009 in New York City, New Y...ntation by visiting the Company,s corporate websit...
(Date:11/25/2009)...., Nov. 25 BioTrends Research Grou... : Stelara report, the first in a multi-phase ...unch of Centocor Ortho-Biotech,s Stelara, from pro...bility. Each wave of the report provides quantita... qualitative information from a subset of 20. The...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2New ways to predict violent behavior 3F 58345 1New ways to predict violent behavior 3F 58345 2Bodys immune system response to dental plaque varies by gender and race 58342 1Bodys immune system response to dental plaque varies by gender and race 58342 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 1Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 3
...TH, N.J., May 15 Schering-Plough,Corporation (NYS...reatment of,chronic hepatitis C virus (HCV) infect...al studies with PEGINTRON(TM) (peginterferon alfa-...erapy, as well as boceprevir, the,company,s invest...sented at,the 39th annual Digestive Disease Week (...
...R, Mich. and TOULOUSE, France, May 15 Cerenis,The...tical company,developing HDL-related compounds for...eases, today announced that it has completed a Pha...y,s lead product candidates.,CER-002 is a peroxiso...ecific agonist in development for the treatment of...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2
(Date:11/26/2009)... Research Triangle Dental (RTDental...h Carolina, today announced the expansion of its s...ER Dentist, Dr. Doug Macmillan. , ...e Dental is pleased to announce that Dr. Doug Macm...y completed an additional advanced training semina...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offerin...sers of Yaz and Yasmin birth control pills who hav... Embolism, Stroke, Heart Attack or other related c...men can call toll free at 1-800-856-6405 or go to ...om and fill out an online case evaluation form. ...
(Date:11/25/2009)..., KANSAS CITY, Mo., Nov. 25 The B...me the nation,s largest medical clinic on Dec. 9-1...f massive free clinics for uninsured people. ,,...he biggest one yet, because it will extend over tw... instead of over a weekend," Sheri Wood, executive...
(Date:11/25/2009)..., TORONTO and CALGARY, Nov. 25 /PRNewswire/ - Sen...gnetic Resonance Imaging (MRI) coils and software ... software enabling technologies, have introduced a...lization software. ,, This innovative interface...d medical imaging offering in the market. Calgary ...
(Date:11/25/2009)..., LONG BEACH, Calif., Nov. 25 Than...1,000 homebound seniors in the greater Long Beach ...r Aging, a program operated by Independence at Hom...than 17 years these organizations have gathered hu...meals to seniors in need in Long Beach, Lakewood, ...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
... study published in the February issue of the Jour...al infection does raise the risk of developing pre...y also indicate that preeclamptic mothers have low... group by almost 64 percent than the non-preeclamp...
...aram, a 55-year-old man in the Indian State of Mad...t 20 years due to a mental illness. // He spends m...s family members. Mansharam was chained after he s...one its best to get him treated, but this did not ...
...irect implantation of stem cells into the pancreas...enhance the production of endogenous insulin. // I...e in the C Peptide levels, and a subsequent decrea... drugs to stimulate the production of insulin. It ...
...overnment is spending large amount of money on the...rnment has to act quickly otherwise the // problem...s are currently rising and is as high as 16% of gr...s and the federal government employees. The proces...
...ood and Drug Administration has allowed the counte...as available only if the patient possesses a presc...lts showed that this drug helped in the reduction ... effects such as gas, incontinence and oily spotti...
...tists belonging to India’s National Institute of I...tant element which helps us to understand how the ...ody. // This will help in developing newer and mo...khale have identified the genes that enable the my...
Other Medicine News:Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2Health News:Demand For Diet Drugs On The Rise 2
Single-Piece Intraocular Lens with haptic eyelets
NaturaLens™ Series Hydrophobic Acrylic Intraocular Lens (Refractive and Bifocal)
STABIBAG Hydrophilic Acrylic Lens
Raysoft Foldable Intraocular Lens
Medicine Products: